As a biomarker, serum albumin not only reflects the body’s nutritional status but also removes inflammatory stimulating factors and alleviates inflammatory responses, indicating to a certain extent the level of systemic inflammation, which is of some value in assessing the prognosis of NSCLC patients (59). This evidence concerns the gene ALB and non-small cell lung carcinoma.